Loading...

Urologix, Inc.

ULGXPNK
Healthcare
Medical - Devices
$0.00
$0.00(0.00%)

Urologix, Inc. ULGX Peers

See (ULGX) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Devices Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
ULGX$0.00+0.00%2.2K-0.01-$0.01N/A
SMMNY$26.84+0.45%120.6B24.84$1.08+1.10%
SEMHF$54.03-1.77%60.6B24.78$2.18+1.83%
RYLPF$23.85+0.00%22.6B79.49$0.30+3.98%
SONVY$58.51+1.49%17.4B25.55$2.29+1.08%
SONVF$284.75-3.04%17B25.24$11.28+1.84%
CHEOY$99.85+0.08%13.1B54.27$1.84+1.40%
SNNUF$14.75+0.00%12.9B31.38$0.47+2.54%
CHEOF$193.04-7.06%12.6B52.60$3.67+1.44%
WILYY$20.19+0.00%9B19.41$1.04N/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

ULGX vs SMMNY Comparison

ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ULGX stands at 2.2K. In comparison, SMMNY has a market cap of 120.6B. Regarding current trading prices, ULGX is priced at $0.00, while SMMNY trades at $26.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ULGX currently has a P/E ratio of -0.01, whereas SMMNY's P/E ratio is 24.84. In terms of profitability, ULGX's ROE is +2.32%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, ULGX is less volatile compared to SMMNY. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.

Stock Price Comparison

Loading...

Frequently Asked Questions

;